Takeda releases internal probe over bad ad

Share this article:

Japanese drugmaker Takeda has released the results of an internal probe over an inappropriate ad for blood pressure medicine BIopress, which, according to the Wall Street Journal, utilized an incorrect chart and “raised suggestions of manipulated trial data.” The company denies wrongdoing. The report is only available in Japanese, however, and WSJ reports that questions regarding an English version have gone unanswered, raising questions on whether the company is trying to be transparent, or merely to appear transparent.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.